Why is Bafna Pharma. falling/rising?

As of 09-Jul, Bafna Pharmaceuticals Ltd's stock price is currently at 85.90, reflecting an increase of 0.47 (0.55%). The stock has shown a trend reversal, gaining after three consecutive days of decline. However, it has underperformed the benchmark in the past week with a decline of 5.01% compared to the Sensex's slight increase of 0.15%. Despite this short-term setback, the stock has performed well over the past month, rising by 14.53%, and has demonstrated strong long-term growth with a remarkable 738.87% increase over the past five years. The company maintains a low Debt to EBITDA ratio of 1.30, indicating a strong ability to service its debt, and has reported healthy growth in net sales and operating profit. However, it is important to note that the stock's profits have fallen by 14.2% over the past year, which may be contributing to mixed investor sentiment.
In the broader market context, while Bafna Pharmaceuticals has outperformed its sector by 0.35% today, the stock's recent performance still lags behind the benchmark in the short term. The decline in delivery volume by 72.02% against the five-day average suggests falling investor participation, which could be a concern for future price movements. Despite the positive results reported for the quarter ending in March, including a significant growth in profit after tax, the overall market sentiment appears cautious, particularly given the stock's underperformance relative to the Sensex over the past three years.